GCT Touts DCD Hoodia Quality

CAPE TOWN, South AfricaGreen Cell Technologies (GCT) completed recent research projects on Hoodia gordonii processed using the companys Dynamic Cellular Disruption (DCD) extraction technology. According to the company, it established a certificated 0.357 percent P57 active/g and up to 0.874 percent active/g for its refined pharma grade hoodia; standard cultivated Hoodia gordonii yields an average P57 active content between 0.06 percent and 0.1 percent using industry standard dry and milling extraction methods. The DCD processing technique allows GCT to offer Hoodia gordonii processed to a variety of particle sizes, from 700 micron to less than 150 micron; it is also more compactable, is readily liquefied into liquid medium, and can be kept in suspension.

In addition, GCT has conducted research studies using Hoodia gordonii DCD extract, and found there are benefits beyond just P57 in using the entire plant. In an unpublished, four-week clinical trial in adults ages 19 to 50 years, consumption of DCD Hoodia lowered blood pressure and cholesterol levels, improved mental focus and stabilized blood sugar levels.

Jan Vlok, head of research and development, GCT, said, In our mission to provide the world with more natural and effective products (on behalf of our clients), we believe that Green Cell Technologies has cracked the code to creating an effective solution to the existing and growing world obesity pandemic through the re-birth of Hoodia gordonii using the DCD process.